Shares Outstanding (Quarterly) Chart

Historical Shares Outstanding (Quarterly) Data

View and export this data back to 2019. Start Trial.
Date Value
June 30, 2026 55.30M
March 31, 2026 55.07M
December 31, 2025 56.22M
September 30, 2025 55.79M
June 30, 2025 56.33M
March 31, 2025 59.43M
December 31, 2024 59.13M
September 30, 2024 59.58M
June 30, 2024 63.23M
March 31, 2024 64.94M
December 31, 2023 64.30M
September 30, 2023 63.98M
June 30, 2023 63.93M
March 31, 2023 63.74M
Date Value
December 31, 2022 63.41M
September 30, 2022 62.64M
June 30, 2022 62.61M
March 31, 2022 62.29M
December 31, 2021 62.02M
September 30, 2021 61.65M
June 30, 2021 61.42M
March 31, 2021 61.31M
December 31, 2020 60.91M
September 30, 2020 60.91M
June 30, 2020 60.91M
March 31, 2020 60.91M
December 31, 2019 60.91M

Shares Outstanding Definition

The volume of stock shares issued by the company and in the hands of the public. This number entails how much is being traded in the open market. A decreasing shares outstanding over time may be the result of company buybacks. Companies frequently make stock buybacks and retire those buybacks as treasury stock.

Read full definition.

Shares Outstanding (Quarterly) Range, Past 5 Years

View Shares Outstanding (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Shares Outstanding (Quarterly) Benchmarks

View Shares Outstanding (Quarterly) Benchmarks
Start Trial
Champions Oncology, Inc. 13.92M
Medpace Holdings, Inc. 27.84M
Avantor, Inc. 676.50M
Personalis, Inc. 106.37M
Adaptive Biotechnologies Corp. 159.06M